The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Open accessAbstract
Natural killer (NK) cells were originally defined as effector lymphocytes of innate immunity endowed with constitutive cytolytic functions. More recently, a more nuanced view of NK cells has emerged. NK cells are now recognized to express a repertoire of activating and inhibitory receptors that is calibrated to ensure self-tolerance while allowing efficacy against assaults such as viral infection and tumor development. Moreover, NK cells do not react in an invariant manner but rather adapt to their environment. Finally, recent studies have unveiled that NK cells can also mount a form of antigen-specific immunologic memory. NK cells thus exert sophisticated biological functions that are attributes of both innate and adaptive immunity, blurring the functional borders between these two arms of the immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Depending on the ligands expressed by the tumor cells studied, different NK-activating receptors may be engaged and trigger cytotoxicity (Vivier et al., 2011).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Vivier et al., 2011
In the citing paper
“Further analysis showed that the translocation of E. hirae to secondary lymphoid organs could exert an adjuvant impact on systemic and local immune responses mediated by CTX [2].”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Lanier, L. L. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,765
Self-citationSelective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,333
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,980
Self-citationMiller, J. S., Soignier, Y., Panoskaltsis‐Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D. H., Le, C. T., DeFor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,894
Kiessling, R. W., Klein, E., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050208 · Cited by 1,827
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,773
Self-citationAdaptive Immune Features of Natural Killer Cells
Sun, J. C., Beilke, J., & Lanier, L. (2009) · Nature · doi:10.1038/nature07665 · Cited by 1,647
Self-citationHerberman, R. B., Nunn, M. E., & Lavrin, D. H. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910160204 · Cited by 1,356
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martin‐Fontecha, A., Thomsen, L. L., Brett, S. J., Gerard, C. J., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,351
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,003
Tang, Y., Li, X., Wang, M., Zou, Q., Zhao, S., Sun, B., Xu, L., & Jiang, Y. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/721782 · Cited by 45
Dou, B., Zhou, W., Li, S., Wang, L., Wu, X., Li, Y., Guan, H., Wang, C., Zhu, S., Ke, Z., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000494587 · Cited by 45
Gil, M., & Kim, K. E. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111993 · Cited by 48
Long noncoding RNA loss in immune suppression in cancer
Hu, Q., Egranov, S. D., Lin, C., & Yang, L. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107591 · Cited by 46
Devillier, R., Chrétien, A.-S., Pagliardini, T., Salem, N., Blaise, D., & Olive, D. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0920-198rr · Cited by 49
Liu, W., Scott, J. M., Langguth, E., Chang, H. L., Park, P. H., & Kim, S. (2020) · iScience · doi:10.1016/j.isci.2020.101709 · Cited by 46
The Adverse Impact of Tumor Microenvironment on NK-Cell
Hu, Z., Xu, X., & Wei, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633361 · Cited by 46
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
Torre, P., Motta, B. M., Sciorio, R., Masarone, M., & Persico, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.781567 · Cited by 49
Bridges, K., & Miller‐Jensen, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.885267 · Cited by 48
Immune–metabolic interactions in homeostasis and the progression to NASH
Hoogerland, J. A., Staels, B., & Dombrowicz, D. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.07.001 · Cited by 46
Vacca, P., Martini, S., Garelli, V., Passalacqua, G., Moretta, L., & Mingari, M. C. (2012) · European Journal of Immunology · doi:10.1002/eji.201242783 · Cited by 45
Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells
Kaur, K., Ko, M.-W., Ohanian, N., Cook, J., & Jewett, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-76702-1 · Cited by 44
Natural Killer–Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy
Cazzetta, V., Franzese, S., Carenza, C., Bella, S. D., Mikulak, J., & Mavilio, D. (2021) · Cancers · doi:10.3390/cancers13092184 · Cited by 47
Zhang, A., Xiao, Z., Liu, Q., Li, P., Xu, F., Liu, J., Tao, H., Feng, L., Song, S., Liu, Z., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100748 · Cited by 44
Next Generation Natural Killer Cells for Cancer Immunotherapy
Rossi, F., Fredericks, N., Snowden, A., Allegrezza, M. J., & Moreno‐Nieves, U. Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.886429 · Cited by 47
Clinical Management of Herpes Simplex Virus Keratitis
Labib, B. A., & Chigbu, D. I. (2022) · Diagnostics · doi:10.3390/diagnostics12102368 · Cited by 44
Mikulak, J., Bozzo, L., Roberto, A., Pontarini, E., Tentorio, P., Hudspeth, K. L., Lugli, E., & Mavilio, D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401114 · Cited by 46
Zhang, X., Jiang, D., & Li, H. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12881 · Cited by 44
Memory of Infections: An Emerging Role for Natural Killer Cells
Rölle, A., Pollmann, J., & Cerwenka, A. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003548 · Cited by 44
Re, V. D., Caggiari, L., Zorzi, M. D., Talamini, R., Racanelli, V., Andrea, M. D., Buonadonna, A., Zagonel, V., Cecchin, E., Innocenti, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084940 · Cited by 43
Involvement of Activating NK Cell Receptors and Their Modulation in Pathogen Immunity
Marras, F., Bozzano, F. M., & Maria, A. D. (2011) · BioMed Research International · doi:10.1155/2011/152430 · Cited by 44
García-Valtanen, P., Martínez‐López, A., López‐Muñoz, A., Belló-Pérez, M., Medina-Gali, R. M., Ortega-Villaizán, M. D. M., Varela, M., Figueras, A. J., Mulero, V., Novoa, B., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00121 · Cited by 42
Mikulak, J., Vito, C. D., Zaghi, E., & Mavilio, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00314 · Cited by 43
High expression of B7-H6 in human glioma tissues promotes tumor progression
Jiang, T., Wu, W., Zhang, H., Zhang, X., Zhang, D.-D., Wang, Q., Huang, L., Wang, Y., & Hang, C. (2017) · Oncotarget · doi:10.18632/oncotarget.16391 · Cited by 44
Local Group 2 Innate Lymphoid Cells Promote Corneal Regeneration after Epithelial Abrasion
Liu, J., Xiao, C., Wang, H., Xue, Y., Dong, D., Lin, C., Song, F., Fu, T., Wang, Z., Chen, J., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.02.010 · Cited by 45
Deng, S., Clowers, M. J., Velasco, W. V., Ramos-Castaneda, M. A., & Moghaddam, S. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01556 · Cited by 45
Klimosch, S. N., Bartel, Y., Wiemann, S., & Steinle, A. (2013) · Blood · doi:10.1182/blood-2013-01-479790 · Cited by 49
Inflammation, Autoimmunity, and Infection in Fibromyalgia: A Narrative Review
Paroli, M., Gioia, C., Accapezzato, D., & Caccavale, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115922 · Cited by 42
Social effects on age-related and sex-specific immune cell profiles in a wild mammal
van Lieshout, S. H. J., Badás, E. P., Mason, M. W. T., Newman, C., Buesching, C. D., Macdonald, D. W., & Dugdale, H. L. (2020) · Biology Letters · doi:10.1098/rsbl.2020.0234 · Cited by 46
Identifying SARS‐CoV‐2 ‘memory’ NK cells from COVID‐19 convalescent donors for adoptive cell therapy
Herrera, L., Martin‐Inaraja, M., Santos, S. J., Inglés‐Ferrándiz, M., Azkarate, A., Pérez-Vaquero, M. Á., Vesga, M. Á., Vicario, J. L., Soria, B., Solano, C., et al. (2021) · Immunology · doi:10.1111/imm.13432 · Cited by 44
Peng, P., Lou, Y., Wang, S., Wang, J., Zhang, Z., Du, P., Zheng, J., Liu, P., & Xu, L. X. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005769 · Cited by 43
SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D
Lee, M. J., Leong, M. W., Rustagi, A., Beck, A., Zeng, L., Holmes, S., Qi, L., & Blish, C. (2022) · bioRxiv · doi:10.1016/j.celrep.2022.111892 · Cited by 31
Clark, J. J., Hoxie, I., Adelsberg, D. C., Sapse, I. A., Andreata‐Santos, R., Yong, J. S., Amanat, F., Tcheou, J., Raskin, A. J., Singh, G., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114922 · Cited by 43
Patel, A. R., Dong, J. C., Trost, B., Richardson, J. S., Tohme, S., Babiuk, S., Kusalik, A., Kung, S. K. P., & Kobinger, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043802 · Cited by 35
Michaelis, S. U., Mezger, M., Bornhäuser, M., Trenschel, R., Stuhler, G., Federmann, B., Oevermann, L., Kanz, L., Handgretinger, R., & Bethge, W. A. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2084-2 · Cited by 43
Natural Killer Cells Modulation in Hematological Malignancies
Baier, C., Fino, A., Sanchez, C., Farnault, L., Rihet, P., Kahn‐Perlès, B., & Costello, R. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00459 · Cited by 47
Natural killer cell-based therapies
Romagné, F., & Vivier, É. (2011) · F1000 Medicine Reports · doi:10.3410/m3-9 · Cited by 43
Albuquerque, K., Tell, D., Lobo, P. A., Millbrandt, L., Mathews, H. L., & Janusek, L. W. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-251 · Cited by 43
Shiraishi, K., Mimura, K., Kua, L., Koh, V., Siang, L. K., Nakajima, S., Fujii, H., Shabbir, A., Yong, W. P., So, J. B. Y., et al. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1197-x · Cited by 43
Speck, N. E., Schuurmans, M. M., Murer, C., Benden, C., & Huber, L. (2016) · Respiratory Research · doi:10.1186/s12931-016-0391-y · Cited by 43
Oliviero, B., Mantovani, S., Varchetta, S., Mele, D., Grossi, G., Ludovisi, S., Nuti, E., Rossello, A., & Mondelli, M. U. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.032 · Cited by 45
Chan, Y. L. T., Zuo, J., Inman, C. F., Croft, W. D., Begum, J., Croudace, J. E., Kinsella, F. A. M., Maggs, L., Nagra, S., Nunnick, J., et al. (2017) · European Journal of Immunology · doi:10.1002/eji.201747134 · Cited by 43
Gumbleton, M., Sudan, R., Fernandes, S., Engelman, R. W., Russo, C. M., Chisholm, J. D., & Kerr, W. G. (2017) · Science Signaling · doi:10.1126/scisignal.aam5353 · Cited by 43
Wu, Z., Wang, M.-R., Liu, Q., Liu, Y., Zhu, K., Chen, L., Guo, H., Li, Y., & Shi, B. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.39056 · Cited by 43
Future of immune checkpoint inhibitors: focus on tumor immune microenvironment
Jia, Y., Liu, L., & Shan, B. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-3735 · Cited by 43
Interaction between Fibroblasts and Immune Cells Following DNA Damage Induced by Ionizing Radiation
Ragunathan, K., Upfold, N. L. E., & Oksenych, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228635 · Cited by 43
Extracellular Vesicles and Their Current Role in Cancer Immunotherapy
Giacobino, C., Canta, M., Fornaguera, C., Borrós, S., & Cauda, V. (2021) · Cancers · doi:10.3390/cancers13092280 · Cited by 43
Tumor immunomodulatory effects of polyphenols
Wang, Q. L., Yang, B., Wang, N., & Gu, J. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1041138 · Cited by 45
New cell sources for CAR-based immunotherapy
Mazinani, M., & Rahbarizadeh, F. (2023) · Biomarker Research · doi:10.1186/s40364-023-00482-9 · Cited by 43
García‐Cuesta, E. M., López-Cobo, S., Álvarez‐Maestro, M., Esteso, G., Romera‐Cárdenas, G., Rey, M., Cassady-Cain, R. L., Linares, A., Valés-Gómez, A., Reyburn, H. T., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00284 · Cited by 42
Dutta, A., Banerjee, A., Saikia, N., Phookan, J., Baruah, M. N., & Baruah, S. (2015) · Cytokine · doi:10.1016/j.cyto.2015.09.006 · Cited by 42
Tang, F., Sally, B., Ciszewski, C., Abadie, V., Curran, S. A., Groh, V., FitzGerald, O., WINCHESTER, R. J., & Jabrì, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076292 · Cited by 42
Shin, D., Park, J.-Y., Jang, Y.-Y., Lee, J., Lee, Y.-K., Shin, M., Jung, J., Carson, W. E., Cho, D., & Kim, S. (2013) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2013.03.006 · Cited by 42
Elderman, M. E., van Beek, A. A., Brandsma, E. T., de Haan, B., Savelkoul, H. F. J., de Vos, P., & Faas, M. M. (2016) · Biology of Sex Differences · doi:10.1186/s13293-016-0075-9 · Cited by 42
Corat, M. A. F., Schlums, H., Wu, C., Theorell, J., Espinoza, D. A., Sellers, S. E., Townsley, D. M., Young, N. S., Bryceson, Y. T., Dunbar, C. E., et al. (2016) · Blood · doi:10.1182/blood-2016-08-734285 · Cited by 42
Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System
Vizcardo, R., Klemen, N. D., Islam, S. M. R., Gurusamy, D., Tamaoki, N., Yamada, D., Koseki, H., Kidder, B. L., Yu, Z., Jia, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.087 · Cited by 40
Duvall, M. G., Krishnamoorthy, N., & Levy, B. D. (2018) · Allergology International · doi:10.1016/j.alit.2018.11.006 · Cited by 43
Natural killer cells as a promising therapeutic target for cancer immunotherapy
Kim, N., Lee, H. H., Lee, H.-J., Choi, W. S., Lee, J., & Kim, H. S. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01143-y · Cited by 44
Kinoshita, T., Maruyama, K., Suyama, K., Nishijima, M., Akamatsu, K., Jogamoto, A., Katakami, K., & Saito, I. (2019) · Food & Function · doi:10.1039/c9fo02128k · Cited by 42
Comprehensive Phenotyping of Human PB NK Cells by Flow Cytometry
Zotto, G. D., Antonini, F., Pesce, S., Moretta, F., Moretta, L., & Marcenaro, E. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24001 · Cited by 42
Phosphorus Dendrimers as Nanotools against Cancers
Caminade, A. (2020) · Molecules · doi:10.3390/molecules25153333 · Cited by 42
Kim, J.-H., Phan, M. T., Kweon, S., Yu, H., Park, J., Kim, K., Hwang, I., Han, S., Kwon, M., & Cho, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01851 · Cited by 42
Yang, N., Lode, K., Berzaghi, R., Islam, A., Martínez-Zubiaurre, I., & Hellevik, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.602530 · Cited by 42
Cippitelli, M., Stabile, H., Kosta, A., Petillo, S., Gismondi, A., Santoni, A., & Fionda, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031103 · Cited by 42
Xia, Y., Brown, Z. J., Huang, H., & Tsung, A. (2021) · Cancer Medicine · doi:10.1002/cam4.4177 · Cited by 42
Colomar-Carando, N., Gauthier, L., Merli, P., Loiacono, F., Canevali, P., Falco, M., Galaverna, F., Rossi, B., Bosco, F., Caratini, M., et al. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0843 · Cited by 42
Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation
Pagliuca, S., Gurnari, C., Hercus, C., Hergalant, S., Hong, S., Dhuyser, A., D’Aveni, M., Aarnink, A., Rubio, M., Feugier, P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38113-4 · Cited by 41
Lisovsky, I., Isitman, G., Song, R., DaFonseca, S., Tremblay-McLean, A., Lebouché, B., Routy, J., Bruneau, J., & Bernard, N. F. (2015) · Journal of Virology · doi:10.1128/jvi.01546-15 · Cited by 41
Bouteiller, P. P. L. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00404 · Cited by 46
Innate Lymphoid Cells in Cancer
Vallentin, B., Barlogis, V., Pipéroglou, C., Cypowyj, S., Zucchini, N., Chéné, M., Navarro, F., Farnarier, C., Vivier, É., & Vely, F. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0222 · Cited by 44
Horowitz, A., Guethlein, L. A., Nemat‐Gorgani, N., Norman, P. J., Cooley, S., Miller, J. S., & Parham, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401990 · Cited by 40
Fend, L., Rusakiewicz, S., Adam, J., Bastien, B., Caignard, A., Messaoudene, M., Iribarren, C., Cremer, I., Marabelle, A., Borg, C., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1163456 · Cited by 41
Self-citationHuman NK cells: From surface receptors to clinical applications
Moretta, L., Pietra, G., Vacca, P., Pende, D., Moretta, F., Bertaina, A., Mingari, M. C., Locatelli, F., & Moretta, A. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.05.007 · Cited by 41
Self-citationPesce, S., Thorén, F. B., Cantoni, C., Prato, C., Moretta, L., Moretta, A., & Marcenaro, E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00510 · Cited by 41
Self-citationBascuas, T., Moreno, M., Grille, S., & Chabalgoity, J. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00007 · Cited by 41
Immune Ecosystem of Virus-Infected Host Tissues
Maarouf, M., Rai, K. R., Goraya, M. U., & Chen, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051379 · Cited by 41
New Insights Into the Biology of CD8 Regulatory T Cells
Nakagawa, H., Wang, L., Cantor, H., & Kim, H. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.09.001 · Cited by 41
Kokowski, K., Stangl, S., Seier, S., Hildebrandt, M., Vaupel, P. W., & Multhoff, G. (2019) · Strahlentherapie und Onkologie · doi:10.1007/s00066-019-01434-9 · Cited by 40
Harnessing Memory NK Cell to Protect Against COVID-19
Soleimanian, S., & Yaghobi, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01309 · Cited by 41
Type 1 innate lymphoid cells: Soldiers at the front line of immunity
Nabekura, T., & Shibuya, A. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.10.001 · Cited by 42
Mechanisms of Kwashiorkor-Associated Immune Suppression: Insights From Human, Mouse, and Pig Studies
Michael, H., Amimo, J. O., Rajashekara, G., Saif, L. J., & Vlasova, A. N. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.826268 · Cited by 44
The innate immune system in transplantation
Oberbarnscheidt, M. H., Zecher, D., & Lakkis, F. G. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.06.006 · Cited by 41
CD11b−CD27− NK Cells Are Associated with the Progression of Lung Carcinoma
Jin, J., Fu, B., Mei, X., Yue, T., Sun, R., Tian, Z., & Wei, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061024 · Cited by 41
Role of NK, NKT cells and macrophages in liver transplantation
Fahrner, R., Dondorf, F., Ardelt, M., Settmacher, U., & Rauchfuß, F. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i27.6135 · Cited by 41
Translating the immune microenvironment of thyroid cancer into clinical practice
Cunha, L. L., & Ward, L. S. (2022) · Endocrine Related Cancer · doi:10.1530/erc-21-0414 · Cited by 40
A Nanotherapeutic Strategy to Reverse NK Cell Exhaustion
Pan, S., Guan, J., Xianyu, B., Tan, Y., Li, T., & Xu, H. (2023) · Advanced Materials · doi:10.1002/adma.202211370 · Cited by 40
Biomaterials to regulate tumor extracellular matrix in immunotherapy
Zhang, Y., Dong, X., Zhang, Y., Chen, Z., Zhou, G., Chen, N., Shen, W., Yang, K., & Pei, P. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.010 · Cited by 40
Adipocyte IL-15 Regulates Local and Systemic NK Cell Development
Liou, Y.-H., Wang, S.-W., Chang, C.-L., Huang, P.-L., Hou, M.-S., Lai, Y., Lee, G. A., Jiang, S., Tsai, C., & Liao, N. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400868 · Cited by 40
Harnessing adaptive natural killer cells in cancer immunotherapy
Liu, L. L., Pfefferle, A., Oei, V. Y. S., Björklund, A. T., Béziat, V., Goodridge, J. P., & Malmberg, K. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.001 · Cited by 40
Know Thyself: NK-Cell Inhibitory Receptors Prompt Self-Tolerance, Education, and Viral Control
Nash, W., Teoh, J. J., Wei, H., Gamache, A., & Brown, M. G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00175 · Cited by 42
Tavakolpour, S., Alavian, S. M., & Sali, S. (2016) · Hepatitis Monthly · doi:10.5812/hepatmon.35810 · Cited by 40
Concerted action of IFN-α and IFN-λ induces local NK cell immunity and halts cancer growth
Lasfar, A., de la Torre, A., Abushahba, W., Cohen-Solal, K., Castaneda, I., Yuan, Y., Reuhl, K. R., Zloza, A., Raveche, E. S., Laskin, D. L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10272 · Cited by 42
Involvement of NK Cells and NKp30 Pathway in Antisynthetase Syndrome
Hervier, B., Perez, M., Allenbach, Y., Devilliers, H., Aubart, F. C., Uzunhan, Y., Ouakrim, H., Dorgham, K., Méritet, J., Longchampt, É., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501902 · Cited by 40
Kronstad, L. M., Seiler, C., Vergara, R., Holmes, S., & Blish, C. A. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800161 · Cited by 38
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma
Zecca, A., Barili, V., Rizzo, D., Olivani, A., Biasini, E., Laccabue, D., Valle, R. D., Ferrari, C. I., Cariani, E., & Missale, G. (2021) · Cells · doi:10.3390/cells10030614 · Cited by 42
Yan, X., Xie, Y., Yang, F., Hua, Y., Zeng, T., Sun, C., Yang, M., Huang, X., Wu, H., Fu, Z., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01949-z · Cited by 41
Pileri, A., Guglielmo, A., Grandi, V., Violetti, S. A., Fanoni, D., Fava, P., Agostinelli, C., Berti, E., Quaglino, P., & Pimpinelli, N. (2021) · Cells · doi:10.3390/cells10102780 · Cited by 42
Ren, Q., Chen, L., Ma, Y., Huang, Y., & Wang, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1563635 · Cited by 42
Anti-tumor and immunomodulatory activity of peptide fraction from the larvae of Musca domestica
Sun, H., Chen, L.-Q., Zhang, J., & Chen, F. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.03.052 · Cited by 39
A chimeric antigen receptor for TRAIL-receptor 1 induces apoptosis in various types of tumor cells
Kobayashi, E., Kishi, H., Ozawa, T., Hamana, H., Nakagawa, H., Jin, A., Lin, Z., & Muraguchi, A. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.024 · Cited by 39
Metadata
- Authors
- Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S.
- Affiliations
- Centre d’Immunologie de Marseille-Luminy (CIML), Université de la Méditerranée UM 631, Campus de Luminy, 13288 Marseille, France.
- University of California, Berkeley (US)
- University of Genoa (IT)
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- Inserm (FR)
- University of California, San Francisco (US)
- Howard Hughes Medical Institute (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Raulet, David H.
- Moretta, Alessandro
- Caligiuri, Michael A.
- Zitvogel, Laurence
- Lanier, Lewis L.
- Yokoyama, Wayne M.
- Ugolini, Sophie
- ORCID
- Venue
- Science
- Published
- 2011-01-07
- Volume
- 331
- Issue
- 6013
- Pages
- 44-49
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3089969
- OpenAlex
- W2146313292
- Cited by
- 2,824
- References
- 78
- Citations by year
- 2026: 133 · 2025: 147 · 2024: 158 · 2023: 142 · 2022: 215 · 2021: 211 · 2020: 222 · 2019: 205 · 2018: 176 · 2017: 211 · 2016: 176 · 2015: 191 · 2014: 199 · 2013: 200 · 2012: 150
- FWCI
- 17.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (R01CA093678, R01CA095137, P01CA095426, CA095137, CA16058, CA 68458, CA95426, CA093678, P30CA016058)
- National Institute of Allergy and Infectious Diseases (AI-068129, R01AI068129, AI51345, R37AI066897, AI039642, AI34385, R01AI033903, AI5716, R01AI051345, AI-33903, R01AI039642, AI066897, R01AI035021, AI035021, P30AI027763)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- natural killer cells, innate immunity, adaptive immunity, NK cell receptors, activating and inhibitory receptors, self-tolerance, cytotoxicity, viral infection, antitumor immunity, immunological memory
- MeSH terms
- Animals, Humans, Immunity, Innate, Immunologic Memory, Killer Cells, Natural, Neoplasms, Receptors, Immunologic, Virus Diseases, Self Tolerance, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
